Ticagrelor doesn’t beat clopidogrel in postfibrinolysis STEMIApril 15, 2019ThrombosisAcute Coronary Syndromes
Despite failed primary endpoint, MI alert device has predictive valueApril 4, 2019Acute Coronary Syndromes
30-day readmissions after STEMI with cardiogenic shock 13%April 2, 2019Acute Coronary SyndromesHeart Failure
More chest compression–only CPR leads to increased survival ratesApril 1, 2019Acute Coronary Syndromes
Ticagrelor reversal agent looks promisingMarch 28, 2019StrokeAcute Coronary SyndromesThrombosisInterventional Cardiology & Surgery
Premature death from heart disease hits Asian subgroups hardMarch 20, 2019HypertensionStrokeAcute Coronary SyndromesPreventive CareLipid Disorders
Immediate angiography after non-STEMI cardiac arrest confers no survival benefitMarch 18, 2019Acute Coronary SyndromesInterventional Cardiology & Surgery
Hormone therapy in transgender individuals may up risk of CV eventsFebruary 18, 2019Acute Coronary SyndromesStrokeLipid Disorders
Biologics curb coronary artery plaques in severe psoriasisFebruary 10, 2019Acute Coronary SyndromesCAD & AtherosclerosisLipid Disorders
ADT harms likely limited to men with CV comorbiditiesFebruary 8, 2019Heart FailureAcute Coronary Syndromes
Impella RP shows higher mortality in postapproval studyFebruary 7, 2019Interventional Cardiology & SurgeryAcute Coronary SyndromesHeart Failure
Stryker issues voluntary field action for Lifepak 15 defibrillatorsFebruary 4, 2019Acute Coronary SyndromesArrhythmias & EP
Hospital Readmissions Reduction Program may be doing more harm than goodJanuary 4, 2019Heart FailureAcute Coronary SyndromesMixed TopicsBusiness of Medicine
